Placid Jover

All filings by Placid Jover on record concern Teva Pharmaceutical Industries Ltd. The record holds 4 filings, for trades running from 1 August 2025 to 3 August 2026.

Sales make up the whole of the open-market record (1 sale, €388k). The rest of the record consists of 3 option exercises. Since January 2026: no purchases and 1 sale on the market.

Most recently, on 5 August 2026, the filings show an open-market sale worth €388k in Teva Pharmaceutical Industries Ltd. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.